AstraZeneca PLC (AZN)
190.00
-3.03
(-1.57%)
USD |
NYSE |
Feb 09, 12:17
AstraZeneca Total Assets (Quarterly) : 114.46B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| GSK Plc | 82.21B |
| Biodexa Pharmaceuticals Plc | -- |
| Mereo BioPharma Group Plc | 53.60M |
| Amgen, Inc. | 90.59B |
| Regeneron Pharmaceuticals, Inc. | 40.56B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 68.48B |
| Shareholders Equity (Quarterly) | 45.89B |
| Debt to Equity Ratio | 0.7111 |
| Current Ratio | 0.8792 |
| Net Debt Paydown Yield | 0.04% |